Hepatitis C Community
Good news In case you have not heard Bristol Myers is
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

Good news In case you have not heard Bristol Myers is

Good news In case you have not heard Bristol Myers is filing in japan for first oral treatment for genotype one .
We are not in Japan but still good news as I think  Gilead and Abbvie will push harder to release there products faster , big companies and money talks .
Also this is good I think because if it was only Gilead in this race , the price of the there treatment would be extremely expensive as Gilead are well known to be very expensive .
Abbvie , Bristol Myers and Gilead will price more fairly I believe now as there is huge market .
2014 should be a good year to many of us .

In the multibillion-dollar race to bring oral hepatitis C treatments to market, Bristol-Myers Squibb  is leapfrogging Gilead Sciences  and Johnson & Johnson by filing for approval for daclatasvir with Japan's Pharmaceutical and Medical Devices Agency.

The daclatasvir and asunaprevir combo therapy is the first all-oral treatment to be filed for approval,  eliminating side-effect-riddled interferon and ribavirin. Bristol's strategic move to go for a Japan launch rather than battle Gilead's sofosbuvir and J&J's simeprevir in the United States is a dramatic shift for the industry and may mark a shift in global drug development toward Japan -- a country in the midst of redefining itself as R&D friendly.
4 Comments Post a Comment
Blank
Avatar_m_tn
Thanks for the info

I read the story but didn't see any dates mentioned.  Lets hope its soon.
Blank
Avatar_m_tn
No dates but if we go by sofosbuvir and simeprevir which have already been fda approval in japan , then the Bristol myers all oral combo therapy good chance will be approved by about May 2014
Blank
Avatar_m_tn
I think you make a good point.  If it wasn't for the profit motive the companies wouldn't be competing so ferociously.  If price is fixed or socialized down investors will invest elsewhere other than drug companies that create new drugs.  Capitalism and competition save lives.
Blank
Avatar_m_tn
Profit motive for these companies is huge we are lucky they have competition prices will much more competitive and fair which will mean  easier access with insurance companies , pbs , developing countries and so forth , if it was a one horse race prices prices would be ridiculous especially with gilead .
My opinion is that Abbvie and Gilead will be filing for fda sooner than many expect as this year just as sofosbuvir was filed earlier than many predicted , there is to much money at stake and money is there only motive .
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
242532_tn?1269553979
Blank
The 3 Essentials to Ending Emotiona...
Sep 18 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Control Emotional Eating with this ...
Sep 04 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Emotional Eating Control: How to St...
Aug 28 by Roger Gould, M.D.Blank
Top Hepatitis Answerers
1815939_tn?1377995399
Blank
pooh55811
Avatar_f_tn
Blank
nan535
Brooklyn, NY
446474_tn?1404424777
Blank
HectorSF
CA
Avatar_f_tn
Blank
Livelife777
683231_tn?1408489117
Blank
flyinlynn
Auburn, WA
Avatar_f_tn
Blank
dontworry_behappy1